Gelatin-based biomaterials as a delivery strategy for osteosarcoma treatment
Osteosarcoma is the most common primary malignant bone tumor. Although surgery and chemoradiotherapy have made some progress in the treatment of osteosarcoma. However, the high recurrence and metastasis rate of osteosarcoma and bone defects caused by surgery are still the main problems faced by oste...
Saved in:
Main Authors: | Qifan Yang, Xingpeng Chen, Jing Liu, Yeteng He |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1537695/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leptin Promotes the Expression of Pro-inflammatory Mediator Genes but Does Not Alter Osteoclastogenesis and Early Stage Differentiation of Osteoblasts
by: Chien-Ning Hsu, et al.
Published: (2024-12-01) -
Towards a new spatial representation of bone remodeling
by: Jason M. Graham, et al.
Published: (2012-02-01) -
Application of loaded graphene oxide biomaterials in the repair and treatment of bone defects: a review
by: Jinyi Xing, et al.
Published: (2024-12-01) -
Gelatin/Poly (Lactic-Co-Glycolic Acid)/Attapulgite Composite Scaffold Equipped with Teriparatide Microspheres for Osteogenesis in vitro and in vivo
by: Zhao Z, et al.
Published: (2025-01-01) -
Bioactive Compounds from Propolis on Bone Homeostasis: A Narrative Review
by: Vanessa Bertolucci, et al.
Published: (2025-01-01)